Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000031

President and CEO sold 13,597 shares at $3.09 ($41,959)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-05 Sale : show line 1 in the form −13,597 $3.09 $41,959 517,958 D
Open-market sales · 13,597 sh · avg $3.09 · $41,959
Loading xslF345X03/wf-form4_164159025635618.xml…